Paper Details

  1. Home
  2. Paper Details

Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.

Author: AaronsonD, BronskyE, ChervinskyP, CohenR, DockhornR, DrdaK, EhtessabianR, FinnA, GrossmanJ, HowlandW, KaiserH, PearlmanD, RatnerP, SettipaneG, SimT, StormsW, SublettJ, WebbR, WoodC

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Perennial rhinitis is a common condition, often requiring multiple agents for complete relief. This study discusses the importance of studies assessing the benefit/risk of combined therapy, particularly for newly approved agents like ipratropium bromide nasal spray 0.03% for rhinorrhea in perennial rhinitis.
Paper Details　
Original Abstract of the Article :
Perennial rhinitis is a common condition that affects up to 10% to 20% of the population. Multiple agents are frequently administered since no single agent provides complete relief. Studies assessing the benefit/risk of combined therapy are important especially for newly approved agents such as ipra...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S1081-1206(10)63284-X

データ提供：米国国立医学図書館（NLM）

Combating Rhinorrhea: A Multifaceted Approach

Perennial rhinitis, a common condition affecting the nasal passages, can significantly impact quality of life. This study examines the effectiveness of ipratropium bromide nasal spray 0.03%, a topical anticholinergic agent, in treating rhinorrhea in perennial rhinitis. The researchers assessed the benefit/risk of ipratropium bromide alone and in combination with beclomethasone nasal spray. Their findings provide valuable insights into the efficacy and safety of ipratropium bromide in treating rhinorrhea.

A New Weapon in the Fight Against Rhinorrhea

This study highlights the potential of ipratropium bromide as an effective treatment for rhinorrhea. The researchers found that ipratropium bromide, alone or in combination with beclomethasone, demonstrated beneficial effects in reducing nasal discharge. This finding offers a new therapeutic option for individuals struggling with rhinorrhea.

Managing Rhinorrhea: A Personalized Approach

This study underscores the importance of considering individual patient needs when treating rhinorrhea. The researchers emphasize the potential for both ipratropium bromide alone and in combination with other treatments to effectively manage rhinorrhea. Their findings highlight the value of personalized treatment approaches in optimizing rhinorrhea management.

Dr.Camel's Conclusion

Rhinorrhea, like a persistent desert sandstorm, can be a frustrating and uncomfortable experience. This study provides valuable insights into the efficacy of ipratropium bromide in combating rhinorrhea. The researchers' findings highlight the importance of exploring new treatment options and customizing therapy to address the unique needs of each individual patient.

Date :
  1. Date Completed 1999-05-19
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

10227333

DOI: Digital Object Identifier

10.1016/S1081-1206(10)63284-X

Related Literature

Article Analysis
・Effects of beclomethasone nasal spray
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.